nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP1A2—Carmustine—malignant glioma	0.397	0.57	CbGbCtD
Cyclobenzaprine—CYP3A4—Temozolomide—malignant glioma	0.3	0.431	CbGbCtD
Cyclobenzaprine—HTR2A—choroid plexus—malignant glioma	0.0245	0.255	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellar cortex—malignant glioma	0.0123	0.129	CbGeAlD
Cyclobenzaprine—HTR2A—pons—malignant glioma	0.00871	0.0909	CbGeAlD
Cyclobenzaprine—HTR2A—vertebral column—malignant glioma	0.00865	0.0902	CbGeAlD
Cyclobenzaprine—VIIth nerve paralysis—Carmustine—malignant glioma	0.00745	0.0402	CcSEcCtD
Cyclobenzaprine—HTR2A—telencephalic ventricle—malignant glioma	0.00717	0.0748	CbGeAlD
Cyclobenzaprine—HTR2A—pineal body—malignant glioma	0.00622	0.0649	CbGeAlD
Cyclobenzaprine—Tongue discolouration—Temozolomide—malignant glioma	0.00611	0.033	CcSEcCtD
Cyclobenzaprine—Cerebration impaired—Temozolomide—malignant glioma	0.00503	0.0271	CcSEcCtD
Cyclobenzaprine—Paranoia—Carmustine—malignant glioma	0.00449	0.0242	CcSEcCtD
Cyclobenzaprine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00392	0.0212	CcSEcCtD
Cyclobenzaprine—Cholestasis—Temozolomide—malignant glioma	0.00389	0.021	CcSEcCtD
Cyclobenzaprine—HTR2A—endothelium—malignant glioma	0.00385	0.0402	CbGeAlD
Cyclobenzaprine—HTR2A—blood vessel—malignant glioma	0.00355	0.037	CbGeAlD
Cyclobenzaprine—Disturbance in attention—Temozolomide—malignant glioma	0.00341	0.0184	CcSEcCtD
Cyclobenzaprine—Thinking abnormal—Carmustine—malignant glioma	0.00334	0.018	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Carmustine—malignant glioma	0.00313	0.0169	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Carmustine—malignant glioma	0.00311	0.0168	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Temozolomide—malignant glioma	0.00303	0.0163	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Temozolomide—malignant glioma	0.00301	0.0162	CcSEcCtD
Cyclobenzaprine—Gynaecomastia—Carmustine—malignant glioma	0.00274	0.0148	CcSEcCtD
Cyclobenzaprine—Mental disability—Carmustine—malignant glioma	0.00265	0.0143	CcSEcCtD
Cyclobenzaprine—Mental disability—Temozolomide—malignant glioma	0.00256	0.0138	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Temozolomide—malignant glioma	0.0024	0.0129	CcSEcCtD
Cyclobenzaprine—Thirst—Temozolomide—malignant glioma	0.00225	0.0122	CcSEcCtD
Cyclobenzaprine—Purpura—Temozolomide—malignant glioma	0.00223	0.012	CcSEcCtD
Cyclobenzaprine—Diplopia—Carmustine—malignant glioma	0.00222	0.012	CcSEcCtD
Cyclobenzaprine—Diplopia—Temozolomide—malignant glioma	0.00215	0.0116	CcSEcCtD
Cyclobenzaprine—Face oedema—Carmustine—malignant glioma	0.00214	0.0116	CcSEcCtD
Cyclobenzaprine—HTR2A—embryo—malignant glioma	0.00212	0.0221	CbGeAlD
Cyclobenzaprine—Ataxia—Carmustine—malignant glioma	0.00209	0.0113	CcSEcCtD
Cyclobenzaprine—Face oedema—Temozolomide—malignant glioma	0.00207	0.0112	CcSEcCtD
Cyclobenzaprine—Ataxia—Temozolomide—malignant glioma	0.00202	0.0109	CcSEcCtD
Cyclobenzaprine—Benzphetamine—POR—malignant glioma	0.00195	0.157	CrCbGaD
Cyclobenzaprine—HTR2A—brainstem—malignant glioma	0.00194	0.0202	CbGeAlD
Cyclobenzaprine—HTR2A—retina—malignant glioma	0.00187	0.0195	CbGeAlD
Cyclobenzaprine—Pancytopenia—Carmustine—malignant glioma	0.00182	0.00984	CcSEcCtD
Cyclobenzaprine—CYP2D6—brainstem—malignant glioma	0.00177	0.0184	CbGeAlD
Cyclobenzaprine—Pancytopenia—Temozolomide—malignant glioma	0.00176	0.0095	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00172	0.0093	CcSEcCtD
Cyclobenzaprine—HTR2A—telencephalon—malignant glioma	0.00172	0.018	CbGeAlD
Cyclobenzaprine—Pollakiuria—Temozolomide—malignant glioma	0.00171	0.00925	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Temozolomide—malignant glioma	0.00171	0.00922	CcSEcCtD
Cyclobenzaprine—Weight increased—Temozolomide—malignant glioma	0.00169	0.00911	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Carmustine—malignant glioma	0.00168	0.00905	CcSEcCtD
Cyclobenzaprine—Stomatitis—Carmustine—malignant glioma	0.00167	0.009	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00162	0.00875	CcSEcCtD
Cyclobenzaprine—Stomatitis—Temozolomide—malignant glioma	0.00161	0.0087	CcSEcCtD
Cyclobenzaprine—CYP2D6—telencephalon—malignant glioma	0.00157	0.0164	CbGeAlD
Cyclobenzaprine—Amitriptyline—NTRK2—malignant glioma	0.00155	0.125	CrCbGaD
Cyclobenzaprine—Hallucination—Carmustine—malignant glioma	0.00153	0.00825	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Carmustine—malignant glioma	0.00153	0.00825	CcSEcCtD
Cyclobenzaprine—Hepatitis—Temozolomide—malignant glioma	0.00148	0.00801	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Temozolomide—malignant glioma	0.00148	0.00797	CcSEcCtD
Cyclobenzaprine—Hallucination—Temozolomide—malignant glioma	0.00148	0.00797	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Temozolomide—malignant glioma	0.00147	0.00795	CcSEcCtD
Cyclobenzaprine—Tinnitus—Temozolomide—malignant glioma	0.00138	0.00747	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Carmustine—malignant glioma	0.00137	0.00741	CcSEcCtD
Cyclobenzaprine—Alopecia—Carmustine—malignant glioma	0.00136	0.00733	CcSEcCtD
Cyclobenzaprine—HTR2A—medulla oblongata—malignant glioma	0.00135	0.0141	CbGeAlD
Cyclobenzaprine—Alopecia—Temozolomide—malignant glioma	0.00131	0.00708	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Temozolomide—malignant glioma	0.00127	0.00683	CcSEcCtD
Cyclobenzaprine—Vision blurred—Carmustine—malignant glioma	0.00126	0.0068	CcSEcCtD
Cyclobenzaprine—Tremor—Carmustine—malignant glioma	0.00125	0.00676	CcSEcCtD
Cyclobenzaprine—HTR2A—midbrain—malignant glioma	0.00124	0.0129	CbGeAlD
Cyclobenzaprine—Agitation—Carmustine—malignant glioma	0.00123	0.00663	CcSEcCtD
Cyclobenzaprine—Vision blurred—Temozolomide—malignant glioma	0.00122	0.00657	CcSEcCtD
Cyclobenzaprine—Tremor—Temozolomide—malignant glioma	0.00121	0.00653	CcSEcCtD
Cyclobenzaprine—HTR2A—spinal cord—malignant glioma	0.00121	0.0126	CbGeAlD
Cyclobenzaprine—Ill-defined disorder—Temozolomide—malignant glioma	0.0012	0.00647	CcSEcCtD
Cyclobenzaprine—Leukopenia—Carmustine—malignant glioma	0.0012	0.00646	CcSEcCtD
Cyclobenzaprine—Agitation—Temozolomide—malignant glioma	0.00119	0.00641	CcSEcCtD
Cyclobenzaprine—Angioedema—Temozolomide—malignant glioma	0.00118	0.00637	CcSEcCtD
Cyclobenzaprine—Malaise—Temozolomide—malignant glioma	0.00116	0.00629	CcSEcCtD
Cyclobenzaprine—Vertigo—Temozolomide—malignant glioma	0.00116	0.00627	CcSEcCtD
Cyclobenzaprine—Convulsion—Carmustine—malignant glioma	0.00116	0.00625	CcSEcCtD
Cyclobenzaprine—Leukopenia—Temozolomide—malignant glioma	0.00116	0.00624	CcSEcCtD
Cyclobenzaprine—Hypertension—Carmustine—malignant glioma	0.00115	0.00623	CcSEcCtD
Cyclobenzaprine—Palpitations—Temozolomide—malignant glioma	0.00114	0.00616	CcSEcCtD
Cyclobenzaprine—Chest pain—Carmustine—malignant glioma	0.00114	0.00614	CcSEcCtD
Cyclobenzaprine—Myalgia—Carmustine—malignant glioma	0.00114	0.00614	CcSEcCtD
Cyclobenzaprine—Anxiety—Carmustine—malignant glioma	0.00113	0.00612	CcSEcCtD
Cyclobenzaprine—Convulsion—Temozolomide—malignant glioma	0.00112	0.00604	CcSEcCtD
Cyclobenzaprine—Hypertension—Temozolomide—malignant glioma	0.00112	0.00602	CcSEcCtD
Cyclobenzaprine—Confusional state—Carmustine—malignant glioma	0.0011	0.00594	CcSEcCtD
Cyclobenzaprine—Myalgia—Temozolomide—malignant glioma	0.0011	0.00594	CcSEcCtD
Cyclobenzaprine—Anxiety—Temozolomide—malignant glioma	0.0011	0.00592	CcSEcCtD
Cyclobenzaprine—Oedema—Carmustine—malignant glioma	0.00109	0.00589	CcSEcCtD
Cyclobenzaprine—Discomfort—Temozolomide—malignant glioma	0.00109	0.00587	CcSEcCtD
Cyclobenzaprine—Dry mouth—Temozolomide—malignant glioma	0.00108	0.00581	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Carmustine—malignant glioma	0.00107	0.00577	CcSEcCtD
Cyclobenzaprine—Tachycardia—Carmustine—malignant glioma	0.00106	0.00575	CcSEcCtD
Cyclobenzaprine—Confusional state—Temozolomide—malignant glioma	0.00106	0.00574	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Temozolomide—malignant glioma	0.00105	0.00569	CcSEcCtD
Cyclobenzaprine—Oedema—Temozolomide—malignant glioma	0.00105	0.00569	CcSEcCtD
Cyclobenzaprine—Anorexia—Carmustine—malignant glioma	0.00104	0.00561	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Temozolomide—malignant glioma	0.00103	0.00557	CcSEcCtD
Cyclobenzaprine—Hypotension—Carmustine—malignant glioma	0.00102	0.0055	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Temozolomide—malignant glioma	0.00102	0.0055	CcSEcCtD
Cyclobenzaprine—Anorexia—Temozolomide—malignant glioma	0.00101	0.00543	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000994	0.00537	CcSEcCtD
Cyclobenzaprine—Insomnia—Carmustine—malignant glioma	0.000987	0.00533	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Carmustine—malignant glioma	0.00098	0.00529	CcSEcCtD
Cyclobenzaprine—HTR2A—central nervous system—malignant glioma	0.000979	0.0102	CbGeAlD
Cyclobenzaprine—Dyspnoea—Carmustine—malignant glioma	0.000973	0.00525	CcSEcCtD
Cyclobenzaprine—Somnolence—Carmustine—malignant glioma	0.00097	0.00524	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000961	0.00519	CcSEcCtD
Cyclobenzaprine—HTR2A—cerebellum—malignant glioma	0.000957	0.00998	CbGeAlD
Cyclobenzaprine—Amitriptyline—NTRK1—malignant glioma	0.000955	0.077	CrCbGaD
Cyclobenzaprine—Insomnia—Temozolomide—malignant glioma	0.000954	0.00515	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Carmustine—malignant glioma	0.000948	0.00512	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Temozolomide—malignant glioma	0.000947	0.00511	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Temozolomide—malignant glioma	0.00094	0.00507	CcSEcCtD
Cyclobenzaprine—Somnolence—Temozolomide—malignant glioma	0.000937	0.00506	CcSEcCtD
Cyclobenzaprine—Constipation—Carmustine—malignant glioma	0.000933	0.00504	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Temozolomide—malignant glioma	0.000928	0.00501	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Temozolomide—malignant glioma	0.000917	0.00495	CcSEcCtD
Cyclobenzaprine—Fatigue—Temozolomide—malignant glioma	0.000909	0.00491	CcSEcCtD
Cyclobenzaprine—CYP3A4—central nervous system—malignant glioma	0.000906	0.00945	CbGeAlD
Cyclobenzaprine—Constipation—Temozolomide—malignant glioma	0.000902	0.00487	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Carmustine—malignant glioma	0.000899	0.00485	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Carmustine—malignant glioma	0.000892	0.00482	CcSEcCtD
Cyclobenzaprine—CYP2D6—central nervous system—malignant glioma	0.000892	0.0093	CbGeAlD
Cyclobenzaprine—CYP2D6—cerebellum—malignant glioma	0.000871	0.00909	CbGeAlD
Cyclobenzaprine—Feeling abnormal—Temozolomide—malignant glioma	0.000869	0.00469	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Carmustine—malignant glioma	0.000862	0.00466	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000862	0.00465	CcSEcCtD
Cyclobenzaprine—Urticaria—Temozolomide—malignant glioma	0.000838	0.00452	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Temozolomide—malignant glioma	0.000833	0.0045	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Carmustine—malignant glioma	0.000804	0.00434	CcSEcCtD
Cyclobenzaprine—Asthenia—Carmustine—malignant glioma	0.000783	0.00423	CcSEcCtD
Cyclobenzaprine—HTR2A—brain—malignant glioma	0.000777	0.00811	CbGeAlD
Cyclobenzaprine—Hypersensitivity—Temozolomide—malignant glioma	0.000777	0.00419	CcSEcCtD
Cyclobenzaprine—Asthenia—Temozolomide—malignant glioma	0.000756	0.00408	CcSEcCtD
Cyclobenzaprine—Diphenhydramine—CYP2C18—malignant glioma	0.000751	0.0605	CrCbGaD
Cyclobenzaprine—Diarrhoea—Carmustine—malignant glioma	0.000746	0.00403	CcSEcCtD
Cyclobenzaprine—Pruritus—Temozolomide—malignant glioma	0.000746	0.00403	CcSEcCtD
Cyclobenzaprine—Carbamazepine—CYP2B6—malignant glioma	0.000732	0.059	CrCbGaD
Cyclobenzaprine—Dizziness—Carmustine—malignant glioma	0.000721	0.00389	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Temozolomide—malignant glioma	0.000721	0.00389	CcSEcCtD
Cyclobenzaprine—CYP2D6—brain—malignant glioma	0.000708	0.00739	CbGeAlD
Cyclobenzaprine—Dizziness—Temozolomide—malignant glioma	0.000697	0.00376	CcSEcCtD
Cyclobenzaprine—Benzphetamine—CYP2B6—malignant glioma	0.000696	0.0561	CrCbGaD
Cyclobenzaprine—Vomiting—Carmustine—malignant glioma	0.000694	0.00374	CcSEcCtD
Cyclobenzaprine—Rash—Carmustine—malignant glioma	0.000688	0.00371	CcSEcCtD
Cyclobenzaprine—Dermatitis—Carmustine—malignant glioma	0.000687	0.00371	CcSEcCtD
Cyclobenzaprine—Headache—Carmustine—malignant glioma	0.000683	0.00369	CcSEcCtD
Cyclobenzaprine—Vomiting—Temozolomide—malignant glioma	0.00067	0.00362	CcSEcCtD
Cyclobenzaprine—Rash—Temozolomide—malignant glioma	0.000665	0.00359	CcSEcCtD
Cyclobenzaprine—Dermatitis—Temozolomide—malignant glioma	0.000664	0.00359	CcSEcCtD
Cyclobenzaprine—Headache—Temozolomide—malignant glioma	0.000661	0.00357	CcSEcCtD
Cyclobenzaprine—Nausea—Carmustine—malignant glioma	0.000648	0.0035	CcSEcCtD
Cyclobenzaprine—Nausea—Temozolomide—malignant glioma	0.000626	0.00338	CcSEcCtD
Cyclobenzaprine—Benzphetamine—SLC6A3—malignant glioma	0.000593	0.0478	CrCbGaD
Cyclobenzaprine—Imipramine—CYP2C18—malignant glioma	0.000567	0.0457	CrCbGaD
Cyclobenzaprine—Diphenhydramine—CYP2B6—malignant glioma	0.000557	0.0449	CrCbGaD
Cyclobenzaprine—Promethazine—CYP2B6—malignant glioma	0.000546	0.0441	CrCbGaD
Cyclobenzaprine—Tamoxifen—CYP2B6—malignant glioma	0.000543	0.0437	CrCbGaD
Cyclobenzaprine—Orphenadrine—CYP2B6—malignant glioma	0.000527	0.0425	CrCbGaD
Cyclobenzaprine—Trimipramine—SLC6A3—malignant glioma	0.000484	0.039	CrCbGaD
Cyclobenzaprine—Imipramine—CYP2B6—malignant glioma	0.000421	0.0339	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP2B6—malignant glioma	0.000418	0.0337	CrCbGaD
Cyclobenzaprine—Nortriptyline—PTGS1—malignant glioma	0.000397	0.032	CrCbGaD
Cyclobenzaprine—Diphenhydramine—PTGS1—malignant glioma	0.000367	0.0296	CrCbGaD
Cyclobenzaprine—Imipramine—SLC6A3—malignant glioma	0.000359	0.0289	CrCbGaD
Cyclobenzaprine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	3.12e-05	0.00346	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	3.08e-05	0.00342	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	2.99e-05	0.00332	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	2.95e-05	0.00328	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	2.93e-05	0.00325	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	2.87e-05	0.00318	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTT1—malignant glioma	2.86e-05	0.00317	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CCR4—malignant glioma	2.81e-05	0.00312	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—HIF1A—malignant glioma	2.8e-05	0.0031	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	2.74e-05	0.00304	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	2.73e-05	0.00303	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—PTGS1—malignant glioma	2.68e-05	0.00297	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	2.66e-05	0.00296	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	2.63e-05	0.00292	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	2.6e-05	0.00289	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	2.59e-05	0.00287	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	2.58e-05	0.00286	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	2.51e-05	0.00278	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	2.49e-05	0.00277	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTT1—malignant glioma	2.42e-05	0.00269	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LATS2—malignant glioma	2.4e-05	0.00267	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	2.33e-05	0.00259	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	2.32e-05	0.00258	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	2.31e-05	0.00257	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	2.31e-05	0.00256	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	2.28e-05	0.00253	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	2.28e-05	0.00253	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—PTGS1—malignant glioma	2.27e-05	0.00252	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—F2—malignant glioma	2.23e-05	0.00247	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CXCR3—malignant glioma	2.09e-05	0.00232	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—RTEL1—malignant glioma	2e-05	0.00222	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	2e-05	0.00222	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	1.99e-05	0.00221	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	1.98e-05	0.0022	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	1.97e-05	0.00218	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	1.95e-05	0.00217	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—BDKRB2—malignant glioma	1.91e-05	0.00212	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	1.87e-05	0.00208	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	1.87e-05	0.00207	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LATS1—malignant glioma	1.82e-05	0.00202	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CXCL8—malignant glioma	1.81e-05	0.00201	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	1.81e-05	0.00201	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	1.77e-05	0.00196	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	1.77e-05	0.00196	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	1.75e-05	0.00194	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL1B—malignant glioma	1.74e-05	0.00193	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—KNG1—malignant glioma	1.74e-05	0.00193	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CASP3—malignant glioma	1.74e-05	0.00193	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—RTEL1—malignant glioma	1.7e-05	0.00188	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	1.68e-05	0.00187	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	1.68e-05	0.00187	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTP1—malignant glioma	1.68e-05	0.00186	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	1.67e-05	0.00186	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	1.65e-05	0.00184	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CCR4—malignant glioma	1.59e-05	0.00176	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	1.5e-05	0.00166	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	1.47e-05	0.00164	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	1.47e-05	0.00164	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCR4—malignant glioma	1.44e-05	0.0016	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—RTEL1—malignant glioma	1.31e-05	0.00145	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	1.29e-05	0.00144	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	1.28e-05	0.00142	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TNF—malignant glioma	1.26e-05	0.0014	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MDK—malignant glioma	1.23e-05	0.00136	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	1.21e-05	0.00135	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCR3—malignant glioma	1.18e-05	0.00131	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	1.17e-05	0.0013	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DTX1—malignant glioma	1.17e-05	0.0013	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—COX8A—malignant glioma	1.15e-05	0.00128	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—F2—malignant glioma	1.12e-05	0.00125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—BDKRB2—malignant glioma	1.08e-05	0.0012	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCR3—malignant glioma	1.07e-05	0.00119	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	1.04e-05	0.00115	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	1.03e-05	0.00114	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—PIK3CA—malignant glioma	9.95e-06	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—KNG1—malignant glioma	9.82e-06	0.00109	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—BDKRB2—malignant glioma	9.8e-06	0.00109	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ASMT—malignant glioma	9.77e-06	0.00109	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—COX8A—malignant glioma	9.74e-06	0.00108	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	9.69e-06	0.00108	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SUFU—malignant glioma	9.31e-06	0.00103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HEY2—malignant glioma	9.2e-06	0.00102	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—BCAN—malignant glioma	9.19e-06	0.00102	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GFAP—malignant glioma	8.98e-06	0.000998	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—KNG1—malignant glioma	8.91e-06	0.00099	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	8.9e-06	0.000989	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	8.7e-06	0.000967	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SPHK1—malignant glioma	8.69e-06	0.000965	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCR4—malignant glioma	8.52e-06	0.000946	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HEY1—malignant glioma	8.52e-06	0.000946	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ASMT—malignant glioma	8.28e-06	0.000919	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HIST1H3B—malignant glioma	8.27e-06	0.000919	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	8.09e-06	0.000899	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CXCL8—malignant glioma	7.91e-06	0.000879	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MMP3—malignant glioma	7.9e-06	0.000877	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—BCAN—malignant glioma	7.78e-06	0.000864	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—JAG2—malignant glioma	7.55e-06	0.000839	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—COX8A—malignant glioma	7.51e-06	0.000835	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—IDH2—malignant glioma	7.41e-06	0.000823	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP2B6—malignant glioma	6.96e-06	0.000773	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—H3F3A—malignant glioma	6.39e-06	0.00071	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ASMT—malignant glioma	6.39e-06	0.00071	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—IDH1—malignant glioma	6.37e-06	0.000707	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—F2—malignant glioma	6.34e-06	0.000705	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCR3—malignant glioma	6.33e-06	0.000703	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—IDH2—malignant glioma	6.27e-06	0.000697	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SPHK1—malignant glioma	6.16e-06	0.000684	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—YWHAE—malignant glioma	6.16e-06	0.000684	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NTRK2—malignant glioma	6.16e-06	0.000684	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FLT1—malignant glioma	6.13e-06	0.000681	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DUSP6—malignant glioma	6.1e-06	0.000678	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CG—malignant glioma	6.07e-06	0.000674	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP2C18—malignant glioma	6.04e-06	0.000671	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—JAG1—malignant glioma	6.02e-06	0.000669	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—BCAN—malignant glioma	6.01e-06	0.000667	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOTCH3—malignant glioma	6e-06	0.000666	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.92e-06	0.000657	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FBXW7—malignant glioma	5.9e-06	0.000656	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2B6—malignant glioma	5.9e-06	0.000655	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BDKRB2—malignant glioma	5.79e-06	0.000643	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—F2—malignant glioma	5.76e-06	0.00064	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT2—malignant glioma	5.56e-06	0.000617	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CG—malignant glioma	5.51e-06	0.000612	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PTPN11—malignant glioma	5.42e-06	0.000602	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—IDH1—malignant glioma	5.4e-06	0.000599	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOTCH2—malignant glioma	5.38e-06	0.000598	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CD—malignant glioma	5.34e-06	0.000593	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KNG1—malignant glioma	5.27e-06	0.000585	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SPHK1—malignant glioma	5.22e-06	0.00058	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2C18—malignant glioma	5.11e-06	0.000568	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT2—malignant glioma	5.04e-06	0.00056	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NTRK1—malignant glioma	5.02e-06	0.000557	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTT1—malignant glioma	4.88e-06	0.000542	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CD—malignant glioma	4.85e-06	0.000538	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—IDH2—malignant glioma	4.84e-06	0.000538	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.82e-06	0.000536	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP3—malignant glioma	4.67e-06	0.000518	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CB—malignant glioma	4.65e-06	0.000517	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDKN2B—malignant glioma	4.62e-06	0.000514	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS1—malignant glioma	4.58e-06	0.000508	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.55e-06	0.000506	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTK2—malignant glioma	4.49e-06	0.000499	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCL8—malignant glioma	4.47e-06	0.000497	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HES1—malignant glioma	4.41e-06	0.00049	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.39e-06	0.000488	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NCOR1—malignant glioma	4.39e-06	0.000487	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—RAF1—malignant glioma	4.33e-06	0.000481	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—IL2—malignant glioma	4.27e-06	0.000475	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—BCHE—malignant glioma	4.25e-06	0.000472	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.24e-06	0.000471	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CB—malignant glioma	4.23e-06	0.000469	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC5A5—malignant glioma	4.2e-06	0.000467	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDGFRA—malignant glioma	4.2e-06	0.000467	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—IDH1—malignant glioma	4.16e-06	0.000462	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTT1—malignant glioma	4.14e-06	0.000459	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SPP1—malignant glioma	4.08e-06	0.000453	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCL8—malignant glioma	4.06e-06	0.000451	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SPHK1—malignant glioma	4.03e-06	0.000447	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.95e-06	0.000438	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL2—malignant glioma	3.88e-06	0.000431	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS1—malignant glioma	3.88e-06	0.00043	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TERT—malignant glioma	3.87e-06	0.000429	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.86e-06	0.000429	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDGFB—malignant glioma	3.77e-06	0.000419	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGFR1—malignant glioma	3.75e-06	0.000417	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HIF1A—malignant glioma	3.7e-06	0.000411	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—BCHE—malignant glioma	3.6e-06	0.0004	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CAV1—malignant glioma	3.58e-06	0.000397	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC5A5—malignant glioma	3.56e-06	0.000395	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KDR—malignant glioma	3.54e-06	0.000393	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FN1—malignant glioma	3.4e-06	0.000378	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—F2—malignant glioma	3.4e-06	0.000378	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTP1—malignant glioma	3.38e-06	0.000376	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.37e-06	0.000374	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BAD—malignant glioma	3.36e-06	0.000374	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.34e-06	0.00037	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOTCH1—malignant glioma	3.33e-06	0.00037	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CAT—malignant glioma	3.29e-06	0.000366	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CD80—malignant glioma	3.26e-06	0.000362	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APC—malignant glioma	3.26e-06	0.000362	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CG—malignant glioma	3.26e-06	0.000362	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EGF—malignant glioma	3.22e-06	0.000358	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTPN11—malignant glioma	3.2e-06	0.000355	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTT1—malignant glioma	3.19e-06	0.000355	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NCOR1—malignant glioma	3.11e-06	0.000345	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BRAF—malignant glioma	3.06e-06	0.00034	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS1—malignant glioma	2.99e-06	0.000332	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT2—malignant glioma	2.98e-06	0.000331	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EGFR—malignant glioma	2.97e-06	0.00033	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.91e-06	0.000323	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTP1—malignant glioma	2.87e-06	0.000318	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	2.86e-06	0.000318	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	2.84e-06	0.000315	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—KRAS—malignant glioma	2.8e-06	0.000311	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CAT—malignant glioma	2.79e-06	0.00031	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—BCHE—malignant glioma	2.78e-06	0.000309	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.75e-06	0.000305	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGF2—malignant glioma	2.74e-06	0.000305	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NCOR1—malignant glioma	2.63e-06	0.000293	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	2.58e-06	0.000286	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MDM2—malignant glioma	2.57e-06	0.000285	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RAF1—malignant glioma	2.56e-06	0.000284	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CAV1—malignant glioma	2.54e-06	0.000282	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	2.53e-06	0.000281	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	2.5e-06	0.000277	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.4e-06	0.000266	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	2.32e-06	0.000257	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.31e-06	0.000256	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.3e-06	0.000255	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.29e-06	0.000255	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARG—malignant glioma	2.23e-06	0.000248	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.21e-06	0.000246	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.17e-06	0.000241	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.16e-06	0.00024	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CAT—malignant glioma	2.15e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CAV1—malignant glioma	2.15e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.1e-06	0.000234	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.05e-06	0.000228	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NCOR1—malignant glioma	2.03e-06	0.000226	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.03e-06	0.000225	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.96e-06	0.000217	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	1.95e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—STAT3—malignant glioma	1.93e-06	0.000214	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARG—malignant glioma	1.89e-06	0.00021	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MYC—malignant glioma	1.79e-06	0.000199	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.77e-06	0.000197	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—malignant glioma	1.75e-06	0.000195	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EGFR—malignant glioma	1.75e-06	0.000195	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.72e-06	0.000191	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CAV1—malignant glioma	1.66e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.66e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTEN—malignant glioma	1.53e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.52e-06	0.000169	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.51e-06	0.000168	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.5e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.49e-06	0.000165	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.47e-06	0.000163	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARG—malignant glioma	1.46e-06	0.000162	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.33e-06	0.000147	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTEN—malignant glioma	1.3e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.24e-06	0.000138	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.16e-06	0.000128	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.15e-06	0.000127	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.08e-06	0.00012	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTEN—malignant glioma	1e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CA—malignant glioma	9.14e-07	0.000101	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKT1—malignant glioma	8.81e-07	9.79e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKT1—malignant glioma	7.47e-07	8.29e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.05e-07	7.83e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKT1—malignant glioma	5.76e-07	6.4e-05	CbGpPWpGaD
